Stock Taper Revenue: $770,000 for Q2 2026, up 56% sequentially and 23% year-over-year.
E-commerce Revenue: $511,000, a record high, representing a 186% increase from Q1 2026 and a 206% increase year-over-year.
Amazon Revenue: Increased 473% sequentially to $349,000, marking a successful transition to in-house management.
Direct-to-Consumer Subscription Revenue: Grew 89% sequentially to $104,000.
Gross Profit: Increased 68% sequentially to $567,000, with gross margins at a record 73.6%.
Net Loss: Improved to $1.8 million from $2.1 million in Q1 2026 and $1.6 million in Q2 2025.
Adjusted EBITDA Loss: Improved 15% sequentially to $1.4 million.
Transitioned from a research-focused organization to a revenue-driven business model.
E-commerce strategy is central to brand building and customer education, with a focus on creating a new category of rodent fertility control.
Launched a redesigned website to enhance customer experience and support digital marketing efforts.
Expanded B2B sales strategy with a dedicated sales team focusing on specific verticals, including pest management and agri-business.
Introduced assessment services to provide customers with objective data on rodent infestations, enhancing service offerings.
The company aims to sustain e-commerce momentum, improve customer retention, and enhance the B2B sales pipeline.
Management is focused on achieving profitability through increased revenue and maintaining gross profit margins.
Future growth is anticipated from new product launches, enhanced marketing efforts, and deeper customer relationships.
No specific revenue guidance was provided for future quarters, but management expressed confidence in the strategic direction.
B2B revenue decreased to $259,000 from $350,000 in Q1 2026, though core B2B revenue showed an 11% sequential increase when excluding one-time orders.
The company is still in the early stages of its transformation, and the full impact of new strategies may take time to materialize.
Concerns about cash burn before reaching profitability were raised, with management acknowledging the need for future capital raises.
Regulatory processes in international markets, particularly Australia, are ongoing and may delay expansion efforts.
Management emphasized the importance of building brand recognition and customer education to support B2B growth.
The sales team is structured by territory with a focus on vertical-specific strategies, allowing for tailored approaches to different market needs.
Future large contracts are anticipated but will require additional time to develop as the new sales team ramps up.
Management is cautious about providing forward guidance on revenue growth but is optimistic about the trajectory based on recent performance.
The company is prioritizing partnerships that can support regulatory processes in international markets, rather than pursuing them independently. Overall, SenesTech demonstrated significant progress in Q2 2026, achieving record revenues and improving gross margins while laying the groundwork for future growth through strategic initiatives. However, challenges remain, particularly in the B2B segment and cash management as the company seeks to reach profitability.
SOURCE: Q2 2026 EARNINGS CALL TRANSCRIPT